B7-CD28 interaction is a late acting co-stimulatory signal for human T cell responses

International Immunology

Volumn 9, Issue 8, 1997, Pages 1095-1102

  Zhang, Yi Qun ^a   Van Neerven, R J Joost ^b,e   Van Gool, Stefaan W ^a,c   Coorevits, Lieve ^a   De Boer, Mark ^d   Ceuppens, Jan L ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^d PanGenetics BV   (Netherlands)

^e ALK ABELLÓ   (Denmark)

Author keywords

Anergy; Antigen presenting cells; CD80; CD86 co stimulation; T lymphocyte activation

Indexed keywords

ALLOANTIGEN; B7 ANTIGEN; CD28 ANTIGEN; CD86 ANTIGEN; CYCLOSPORIN A; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 5; MONOCLONAL ANTIBODY; T LYMPHOCYTE RECEPTOR;

ANTIGEN PRESENTING CELL; ARTICLE; B LYMPHOCYTE; CELLULAR IMMUNITY; CLONAL ANERGY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; LYMPHOCYTE CULTURE; LYMPHOCYTE PROLIFERATION; MONOCYTE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; VIRUS CELL TRANSFORMATION;

ANTIGEN-PRESENTING CELLS; ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, CD80; ANTIGENS, DIFFERENTIATION; CELL COUNT; CLONAL ANERGY; CYTOKINES; HUMANS; IMMUNOCONJUGATES; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTES; TIME FACTORS;

EID: 8544279649     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/9.8.1095     Document Type: Article

References (40)

1. June, C. H., Bluestone, J. A., Nadler L. M. and Thompson, C. B. 1994. The B7 and CD28 receptor families, Immunol. Today 15:321.
2. Lenschow, D. J., Walunas, T. L. and Bluestone, J. A. 1996. CD28/ B7 system of T cell co-stimulation. Annu. Rev. Immunol. 14:233.
3. Caux, C., Vanbervliet, B., Massacrier, C., Azuma, M., Okumura, K., Lanier, L. L. and Banchereau, J. 1994. B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells. J. Exp. Med. 180:1841.
4. Baroja, M. L., Lorre, K. Van Vaeck, F. and Ceuppens, J. L. 1989. The anti-T cell monoclonal antibody 9.3 (anti-CD28) provides a helper signal and bypasses the need for accessory cells in T cell activation with immobilized anti-CD3 and mitogens. Cell. Immunol. 120:205.
5. Thompson, C. B., Lindsten, T., Ledbetter, J. A., Kunkel, S. L., Young, H. A., Emerson, S. G., Leiden, J. M. and June, C. H. 1989. CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines. Proc. Natl Acad. Sci. USA 86:1333.
6. Gimmi, C. D., Freeman, G. J., Gribben, J. G., Sugita, K., Freedman, A. S., Morimoto, C. and Nadler, L. M. 1991. B-cell surface antigen B7 provides a co-stimulatory signal that induces T cells to proliferate and secrete interleukin 2. Proc. Natl Acad. Sci. USA 88:6575.
7. Azuma, M., Ito, D., Yagita, H., Okumura, K., Phillips, J. H., Lanier, L. L. and Somoza, C. 1993. B70 antigen is a second ligand for CTLA-4 and CD28. Nature 366:76.
8. Van Gool, S. W., de Boer, M. and Ceuppens, J. L. 1993 CD28 Ligation by monoclonal antibodies or B7/BB1 provides an accessory signal for the cyclosporin A-resistant generation of cytotoxic T cell activity. J. Immunol. 150:3254.
9. Linsley, P. S., Brady, W., Urnes, M., Grosmaire, L. S., Damle, N. K, and Ledbetter, J. A. 1991. CTLA-4 is a second receptor for the B cell activation antigen B7. J. Exp. Med. 174:561.
10. Walunas, T. L., Lenschow, D. J., Bakker, C. Y., Linsley, P. S., Freeman, G. J., Green, J. M., Thompson, C. B. and Bluestone, J. A. 1994. CTLA-4 can function as a negative regulator of T cell activation. Immunity 1:405.
11. Krummel, M. F. and Allison, J. P. 1995. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J. Exp. Med. 182:459.
12. Waterhouse, P., Penninger, J. M., Timms, E., Wakeham, A., Shahinian, A., Lee, K. P., Thompson, C. B., Griesser, H, and Mak, T. W, 1995. Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4. Science 270:985.
13. Tan, P., Anasetti, C., Hansen, J. A., Melrose, J., Brunvand, M., Bradshaw, J., Ledbetter, J. A. and Linsley, P. S. 1993. Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1. J. Exp. Med. 177:165.
14. Linsley, P. S., Wallace, P. M., Johnson, J., Gibson, M. G., Greene, J. L., Ledbetter, J. A., Singh, C, and Tepper, M. A. 1992. Immnunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule. Science 257:792.
15. Lenschow, D. J., Zeng, Y. J., Thistlethwaite, J. R., Montag, A., Brady, W., Gibson, M. G., Linsley, P. S. and Bluestone, J. A. 1992. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4-lg. Science 257:789.
16. Lin, H., Bolling, S. F., Linsley, P. S., Wei, R. Q., Gordon, D., Thompson, C. B. and Turka, L. A. 1993. Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4-lg plus donor-specific transfusion. J. Exp. Med. 178:1801.
17. McLellan, A. D., Starling, G. C., Williams, L. A., Hock, B. D. and Hart, D. N. J. 1995. Activation of human peripheral blood dendritic cells induces the CD86 co-stimulatory molecule. Eur. J. Immunol. 25:2064.
18. Freedman, A. S., Freeman, G. J., Rhynhart, K. and Nadler, L. M. 1991. Selective induction of B7/BB1 on interferon-γ stimulated monocytes: a potential mechanism for amplification of T cell activation through the CD28 pathway. Cell. Immunol. 137:429.
19. Barcy, S., Wettendorff, M., Leo, O., Urbain, J., Kruger, M., Ceuppens, J. L. and de Boer, M., 1995. FcR cross-linking on monocytes results in impaired T cell stimulatory capacity. Int. Immunol. 7:179.
20. Hathcock, K. S., Laszlo, G., Pucillo, C., Linsley, P. and Hodes, R. J. 1994. Comparative analysis of B7-1 and B7-2 co-stimulatory ligands: expression and function. J. Exp. Med. 180:631.
21. Foy, T. M., Aruffo, A., Bajorath, J., Buhlmann, J. E. and Noelle, R. J. 1996. Immune regulation by CD40 and its ligand gp39. Annu. Rev. Immunol. 14:591.
22. Lorré, K., Van Damme, J. Verwilghen, J., Baroja, M. L. and Ceuppens, J. L. 1990. IL-6 is an accessory signal in the alternative CD2-mediated pathway of T cell activation. J. Immunol. 144:4681.
23. de Boer, M., Conroy, L., Min, H. Y. and Kwekkeboom, J. 1992. Generation of monoclonal antibodies to human lymphocyte cell surface antigens using insect cells expressing recombinant proteins. J. Immunol. Methods 152:15.
24. de Boer, M., Parren, P., Dove, J., Ossendorp, F., Van de Horst, G. and Reeder, J. 1992. Functional characterization of a novel anti-B7 monoclonal antibody. Eur. J. Immunol. 22:3071.
25. Van Gool, S. W., Delabie, J., Vandenberghe, P., Coorevits, L., De Wolf-Peeter, C. and Ceuppens, J. L. 1997. Expression of B7-2 (CD86) molecules by Reed-Sternberg cells of Hodgkin's disease Leukemia, in press.
26. Wierenga, E. A., Snoek, M., Bos, J. D., Jansen, H. M. and Kapsenberg, M. L. 1990. Comparison of diversity and function of house dust mite-specific T lymphocyte clones from atopic and non-atopic donors. Eur. J. Immunol. 20:1519.
27. Van Gool, S. W., Ceuppens, J. L. Walter, H. and De Boer, M. 1994. Synergy between cyclosporin A and a monoclonal antibody to B7 in blocking alloantigen-induced T-cell activation. Blood 83:175.
28. Baroja, M. L. and Ceuppens, J. L. 1987. More exact quantification of interleukin-2 production by addition of anti-Tac monoclonal antibody to cultures of stimulated lymphocytes. J. Immunol. Methods 98:267.
29. Van Gool, S. W., de Boer, M. and Ceuppens, J. L. 1994. The combination of anti-B7 monoclonal antibody and cyclosporin A induces alloantigen-specific anergy during a primary mixed lymphocyte reaction. J Exp. Med. 179:715.
30. Zhang, Y., van Neerven, J., Kasran, A., de Boer, M. and Ceuppens, J. L. 1996. Differential requirements for co-stimulatory signals from B7 family members by resting versus recently activated memory T cells towards soluble recall antigens. Int. Immunol. 8:37.
31. Lindsten, T., June, C, H., Ledbetter, J. A., Stella, G. and Thompson, C. B. 1989. Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway. Science 244:339.
32. L. Immunity 3:87.
33. Linsley, P. S., Greene, J. L., Brady, W., Bajorath, J., Ledbetter, J. A. and Peach, R. 1995. Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors. Immunity 1:793.
34. Quill, H. 1996. Anergy as a mechanism of peripheral T cell tolerance. J. Immunol, 156:1325.
35. Boussiotis, V. A., Barber, D. L., Nakarai, T., Freeman, G. J., Gribben, J. G., Bernstein, G. M., D'Andrea, A. D., Ritz, J. and Nadler, L. M. 1994. Prevention of T cell anergy by signaling through the γ chain of the IL-2 receptor. Science 266:1039.
36. Green, J. M., Noel, P. J., Sperling, A. I., Walunas, T. L., Gray, G. S., Bluestone, J. A. and Thompson, C. B. 1994. Absence of B7-dependent responses in CD28-deficient mice. Immunity 1:501.
37. Lucas, P. J., Negishi, I., Nakayama, K., Fields, L. E. and Loh, D. Y. 1995. Naive CD28-deficient T cells can initiate but not sustain an in vitro antigen-specific immune response. J. Immunol. 154:5757.
38. Sperling A. I., Auger, J. A., Ehst, B. D., Rulifson, I. C., Thompson, C. B. and Bluestone, J. A. 1996. CD28/B7 interactions deliver a unique signal to naieve T cells that regulate cell survival but not early proliferation. J. Immunol. 157:3909.
39. Kündig, T. M., Shahinian, A., Kawai, K., Mittrücker, H. W., Sebzda, E., Backmann, M. F., Mak,T. W. and Ohashi, P. S. 1996 Duration of TCR stimulation determines co-stimulatory requirement of T cells. Immunity 5:41
40. Nusslein, H. G., Frosch, K. H., Woith, W., Lane, P., Kalden, J. R. and Manger, B. 1996. Increase of intracellular calcium is the essential signal for the expression of CD40 ligand. Eur. J. Immunol. 26:846.